Sustained Norepinephrine Stimulation Induces Different Regulation of Expression in Three Α1-Adrenoceptor Subtypes

Beilei Lei,Youyi Zhang,Chide Han
DOI: https://doi.org/10.1016/s0024-3205(01)01115-8
IF: 6.78
2001-01-01
Life Sciences
Abstract:The norepinephrine (NE) -induced regulation of α1-adrenoceptors (ARs) expression in human embryonic kidney (HEK) 293 cells stably expressing cloned α1-AR subtypes with similar receptor densities was investigated. In the presence of 10 μM propranolol, the treatment of cells with 10 μM NE for 4 –72 h down-regulated α1A- and α1D-AR, but increased α1B-AR expression in a time-dependent manner. The down-regulation of α1A-AR reached maximum of 40.3 ± 14.7 % at 48h. The down-regulation of α1D-AR reached maximum of 51.3 ± 3.7 % at 24h. With the stimulation of NE, α1B-AR density was increased maximally by 112.4 ± 43.4 % at 48h. The protein kinase C (PKC) inhibitor calphostin C or Ro-31-8220 abolished the NE-induced down-regulation of α1A- and α1D-AR, but showed no effect on the up-regulation of α1B-AR. The PKC agonist PMA not only mimicked the NE-induced down-regulation of α1A- and α1D-AR, but also induced a down-regulation of α1B-AR. The endoplasmic reticulum Ca2+-ATPase inhibitor cyclopiazonic acid (CPA) or thapsigargin, or the calcium chelator BAPTA/AM did not affect the down-regulation of α1A-AR, but inhibited the up-regulation of α1B-AR induced by NE. Calmodulin antagonist W-7, tyrosine kinase inhibitor genistein or tyrphostin A25 had no effect on NE-induced up-regulation of α1B-AR. The results suggest that three α1-AR subtypes are differently regulated by sustained NE stimulation with different signal transduction pathways.
What problem does this paper attempt to address?